Danish drug maker Novo Nordisk has struck partnerships with 10 Indian artificial intelligence (AI) startups to streamline its ...

Baird Asset Management controlled Chautauqua Capital Management, a boutique investment firm, released the “Baird Chautauqua ...

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...

Novo Nordisk, whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

I nvesting in biotech stocks is a fantastic way to grow your money over time. This is because in the early days of these ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

CNBC purchased what appeared to be Novo Nordisk's Ozempic from a company called Laver Beauty for a fraction of its U.S. list ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...